$0.095
-0.090 (-94.69%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
CERO stock price ended at $0.10 on Thursday, after losing -94.69%
CERo Therapeutics Holdings Inc (CERO) last closed at $0.0951, losing -94.69%. These facts feed the 1-day and 1-week CERO price prediction above.
Forecast Drivers
CERo Therapeutics Holdings Inc (CERO) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Seasonality analysis for CERO
Historically the probability of a positive August return for CERO is 0.00%. January offers the highest probability of a positive month at 43.90%, while March is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for CERO
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Aug 2026 | $7.05 | $7.79 | $9.34 | +8092.98% |
| Sep 2026 | $8.26 | $8.33 | $9.29 | +8657.97% |
| Oct 2026 | $9.86 | $10.05 | $11.48 | +10471.26% |
| Nov 2026 | $10.27 | $10.54 | $12.33 | +10984.62% |
| Dec 2026 | $9.07 | $9.27 | $10.66 | +9642.64% |
In 2026, CERo Therapeutics Holdings Inc (CERO) is projected to range from $7.05 to $12.33.
CERo Therapeutics Holdings Inc 2026 monthly forecast
In Aug 2026, CERo Therapeutics Holdings Inc is projected to average $7.79, with a low of $7.05 and high of $9.34.
In Sep 2026, CERo Therapeutics Holdings Inc is projected to average $8.33, with a low of $8.26 and high of $9.29.
In Oct 2026, CERo Therapeutics Holdings Inc is projected to average $10.05, with a low of $9.86 and high of $11.48.
In Nov 2026, CERo Therapeutics Holdings Inc is projected to average $10.54, with a low of $10.27 and high of $12.33.
In Dec 2026, CERo Therapeutics Holdings Inc is projected to average $9.27, with a low of $9.07 and high of $10.66.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.